These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22683086)

  • 1. Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation.
    Krawitz PM; Murakami Y; Hecht J; Krüger U; Holder SE; Mortier GR; Delle Chiaie B; De Baere E; Thompson MD; Roscioli T; Kielbasa S; Kinoshita T; Mundlos S; Robinson PN; Horn D
    Am J Hum Genet; 2012 Jul; 91(1):146-51. PubMed ID: 22683086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome.
    Krawitz PM; Murakami Y; Rieß A; Hietala M; Krüger U; Zhu N; Kinoshita T; Mundlos S; Hecht J; Robinson PN; Horn D
    Am J Hum Genet; 2013 Apr; 92(4):584-9. PubMed ID: 23561847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIGO mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels.
    Nakamura K; Osaka H; Murakami Y; Anzai R; Nishiyama K; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Kinoshita T; Matsumoto N; Saitsu H
    Epilepsia; 2014 Feb; 55(2):e13-7. PubMed ID: 24417746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineation of PIGV mutation spectrum and associated phenotypes in hyperphosphatasia with mental retardation syndrome.
    Horn D; Wieczorek D; Metcalfe K; Barić I; Paležac L; Cuk M; Petković Ramadža D; Krüger U; Demuth S; Heinritz W; Linden T; Koenig J; Robinson PN; Krawitz P
    Eur J Hum Genet; 2014 Jun; 22(6):762-7. PubMed ID: 24129430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype-genotype correlations of PIGO deficiency with variable phenotypes from infantile lethality to mild learning difficulties.
    Tanigawa J; Mimatsu H; Mizuno S; Okamoto N; Fukushi D; Tominaga K; Kidokoro H; Muramatsu Y; Nishi E; Nakamura S; Motooka D; Nomura N; Hayasaka K; Niihori T; Aoki Y; Nabatame S; Hayakawa M; Natsume J; Ozono K; Kinoshita T; Wakamatsu N; Murakami Y
    Hum Mutat; 2017 Jul; 38(7):805-815. PubMed ID: 28337824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in PIGL in a patient with Mabry syndrome.
    Fujiwara I; Murakami Y; Niihori T; Kanno J; Hakoda A; Sakamoto O; Okamoto N; Funayama R; Nagashima T; Nakayama K; Kinoshita T; Kure S; Matsubara Y; Aoki Y
    Am J Med Genet A; 2015 Apr; 167A(4):777-85. PubMed ID: 25706356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperphosphatasia with mental retardation syndrome type 4 In two siblings-expanding the phenotypic and mutational spectrum.
    Akgün Doğan Ö; Demir GÜ; Kosukcu C; Taskiran EZ; Simsek-Kiper PÖ; Utine GE; Alikaşifoğlu M; Boduroğlu K
    Eur J Med Genet; 2019 Jun; 62(6):103535. PubMed ID: 30217754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome.
    Murakami Y; Kanzawa N; Saito K; Krawitz PM; Mundlos S; Robinson PN; Karadimitris A; Maeda Y; Kinoshita T
    J Biol Chem; 2012 Feb; 287(9):6318-25. PubMed ID: 22228761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare Noncoding Mutations Extend the Mutational Spectrum in the PGAP3 Subtype of Hyperphosphatasia with Mental Retardation Syndrome.
    Knaus A; Awaya T; Helbig I; Afawi Z; Pendziwiat M; Abu-Rachma J; Thompson MD; Cole DE; Skinner S; Annese F; Canham N; Schweiger MR; Robinson PN; Mundlos S; Kinoshita T; Munnich A; Murakami Y; Horn D; Krawitz PM
    Hum Mutat; 2016 Aug; 37(8):737-44. PubMed ID: 27120253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability.
    Hansen L; Tawamie H; Murakami Y; Mang Y; ur Rehman S; Buchert R; Schaffer S; Muhammad S; Bak M; Nöthen MM; Bennett EP; Maeda Y; Aigner M; Reis A; Kinoshita T; Tommerup N; Baig SM; Abou Jamra R
    Am J Hum Genet; 2013 Apr; 92(4):575-83. PubMed ID: 23561846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation.
    Howard MF; Murakami Y; Pagnamenta AT; Daumer-Haas C; Fischer B; Hecht J; Keays DA; Knight SJ; Kölsch U; Krüger U; Leiz S; Maeda Y; Mitchell D; Mundlos S; Phillips JA; Robinson PN; Kini U; Taylor JC; Horn D; Kinoshita T; Krawitz PM
    Am J Hum Genet; 2014 Feb; 94(2):278-87. PubMed ID: 24439110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder.
    Thompson MD; Knaus AA; Barshop BA; Caliebe A; Muhle H; Nguyen TTM; Baratang NV; Kinoshita T; Percy ME; Campeau PM; Murakami Y; Cole DE; Krawitz PM; Mabry CC
    Eur J Med Genet; 2020 Apr; 63(4):103822. PubMed ID: 31805394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome.
    Krawitz PM; Schweiger MR; Rödelsperger C; Marcelis C; Kölsch U; Meisel C; Stephani F; Kinoshita T; Murakami Y; Bauer S; Isau M; Fischer A; Dahl A; Kerick M; Hecht J; Köhler S; Jäger M; Grünhagen J; de Condor BJ; Doelken S; Brunner HG; Meinecke P; Passarge E; Thompson MD; Cole DE; Horn D; Roscioli T; Mundlos S; Robinson PN
    Nat Genet; 2010 Oct; 42(10):827-9. PubMed ID: 20802478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: a case report.
    Fu L; Liu Y; Chen Y; Yuan Y; Wei W
    BMC Pediatr; 2019 Feb; 19(1):68. PubMed ID: 30813920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphosphatasia with mental retardation syndrome, expanded phenotype of
    Altassan R; Fox S; Poulin C; Buhas D
    Mol Genet Metab Rep; 2018 Jun; 15():46-49. PubMed ID: 30023290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperphosphatasia with mental retardation syndrome type 4 in three unrelated South African patients.
    Bezuidenhout H; Bayley S; Smit L; Kinnear C; Möller M; Uren C; Urban MF
    Am J Med Genet A; 2020 Oct; 182(10):2230-2235. PubMed ID: 32845056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal presentation of Mabry syndrome with congenital diaphragmatic hernia and phenotypic overlap with Fryns syndrome.
    Reynolds KK; Juusola J; Rice GM; Giampietro PF
    Am J Med Genet A; 2017 Oct; 173(10):2776-2781. PubMed ID: 28817240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphosphatasia-mental retardation syndrome due to PIGV mutations: expanded clinical spectrum.
    Horn D; Krawitz P; Mannhardt A; Korenke GC; Meinecke P
    Am J Med Genet A; 2011 Aug; 155A(8):1917-22. PubMed ID: 21739589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic analysis of two Chinese infants with Mabry syndrome.
    Xue J; Li H; Zhang Y; Yang Z
    Brain Dev; 2016 Oct; 38(9):807-18. PubMed ID: 27177984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGAP3-related hyperphosphatasia with mental retardation syndrome: Report of 10 new patients and a homozygous founder mutation.
    Abdel-Hamid MS; Issa MY; Otaify GA; Abdel-Ghafar SF; Elbendary HM; Zaki MS
    Clin Genet; 2018 Jan; 93(1):84-91. PubMed ID: 28390064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.